Meant to evaluate the efficacy and safety of sildenafil cream in premenopausal patients with Female Sexual Arousal Disorder (FSAD)
Patient and Partner are eligible for the study separately.
Other assessments apply for partner.
Study is 22 weeks with 7 visits and follow up phone assessment.
To qualify for the trial you must:
- Patient must be a premenopausal woman, 21 years or older
- Patient has been in a stable, monogamous, sexually active, relationship for at least 6 months
- Other criteria may apply*
*Eligibility for studies may require specific demographics such as age and/or symptoms.
Eligible candidates will be compensated for time and travel.
To learn more about this trial and to find out if you qualify, please call 402.934.0044 or complete the form on our contact page.